0001567619-21-015554.txt : 20210813
0001567619-21-015554.hdr.sgml : 20210813
20210813172202
ACCESSION NUMBER: 0001567619-21-015554
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210811
FILED AS OF DATE: 20210813
DATE AS OF CHANGE: 20210813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCarthy Sean A.
CENTRAL INDEX KEY: 0001654058
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37587
FILM NUMBER: 211173425
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD.
STREET 2: SUITE 100
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CytomX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001501989
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273521219
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.515.3185
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD.
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2021-08-11
0
0001501989
CytomX Therapeutics, Inc.
CTMX
0001654058
McCarthy Sean A.
C/O CYTOMX THERAPEUTICS, INC.
151 OYSTER POINT BLVD., STE. 400
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Common Stock
2021-08-11
4
M
0
92113
1.1339
A
99922
D
Common Stock
93158
I
See footnote
Stock Option (Right to Buy)
1.1339
2021-08-11
4
M
0
92113
0.00
D
2021-09-20
Common Stock
92113
0
D
Amount of securities held has been adjusted to reflect the transfer of 40 shares previously owned directly to Sean A. McCarthy 2018 Trust.
Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
Exercise of September 2021 expiring stock options with cash.
100% of the shares subject to the option are fully vested and exercisable.
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
2021-08-13